DaleLeeBixbyMD

PubMed

• Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
  Altman, J., Zuckerman, T., Koprivnikar, J., McCloskey, J., Kota, V., Keng, M., Frankfurt, O., Abaza, Y., Bixby, D., Emadi, A., Burch, M., Bhatnagar, B., Luger, S., Per...> ;Blood Advances. 2023 Dec 26
• Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up.
  Christy J Khouderchah, Lydia L Benitez, Bernard L Marini, Martina Fraga, Kristen Pettit, Patrick W Burke, Dale L Bixby, Anthony J Perissinotti> ;Leukemia & Lymphoma. 2024 Feb 1
• Real-world outcomes with immunosuppressive therapy for aplastic anemia in patients treated at the University of Michigan.
  Charles E Foucar, Daniel H Foley, Jessica Aldous, Patrick W Burke, Kristen R Pettit, Lydia L Benitez, Anthony J Perissinotti, Bernard L Marini, Philip Boonstra, Dale L...> ;European Journal of Haematology. 2024 Mar 1
• 1 citations
  T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment.
  Marc Gutierrez, Patrick Bladek, Busra Goksu, Carlos Murga-Zamalloa, Dale Bixby, Ryan Wilcox> ;International Journal of Molecular Sciences. 2023 Jul 28
• 12 citations
  Targeting RARA overexpression with tamibarotene, a potent and selective RARα agonist, is a novel approach in AML.
  Stéphane de Botton, Thomas Cluzeau, Carlos Vigil, Rachel J Cook, Philippe Rousselot, David A Rizzieri, Jane L Liesveld, Pierre Fenaux, Thorsten Braun, Anne Banos, Jose...> ;Blood Advances. 2023 May 9
• 12 citations
  North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need.
  Naveen Pemmaraju, Hagop Kantarjian, Kendra Sweet, Eunice Wang, Jayastu Senapati, Nathaniel R Wilson, Marina Konopleva, Arthur E Frankel, Vikas Gupta, Ruben Mesa, Matth...> ;Blood. 2023 Feb 9
• 2 citations
  A phase Ib trial of mivavotinib (TAK-659), a dual SYK/FLT3 inhibitor, in patients with relapsed/refractory acute myeloid leukemia.
  Keith W Pratz, Jason Kaplan, Moshe Levy, Dale Bixby, Patrick W Burke, Harry Erba, Trisha M Wise-Draper, Gail J Roboz, Nikolaos Papadantonakis, Trivikram Rajkhowa, Dani...> ;Haematologica. 2023 Mar 1
• 3 citations
  ERG amplification is a secondary recurrent driver event in myeloid malignancy with complex karyotype and TP53 mutations.
  Winston Y Lee, Efrain A Gutierrez-Lanz, Hong Xiao, David McClintock, May P Chan, Dale L Bixby, Lina Shao> ;Genes, Chromosomes & Cancer. 2022 Jul 1
• Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase.
  YeeAnn Chen, Kaitlyn Buhlinger, Anthony J Perissinotti, Allison J Schepers, Lydia Benitez, Jessica Auten, Sheh-Li Chen, Dale L Bixby, Patrick W Burke, Kristen M Pettit...> ;Leukemia & Lymphoma. 2022 Nov 1
• 3 citations
  Oncology stewardship in acute myeloid leukemia.
  Madeleine A Ochs, Bernard L Marini, Anthony J Perissinotti, Charles E Foucar, Kristen Pettit, Patrick Burke, Dale L Bixby, Lydia L Benitez> ;Annals of Hematology. 2022 Aug 1
• 1 citations
  Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia.
  Madeleine A Ochs, Bernard L Marini, Lydia L Benitez, Sarah E Stump, Taylor M Weis, Kaitlyn M Buhlinger, Thomas Diaz, Justin H Reid, Benyam Muluneh, Kristen Pettit, Pat...> ;Leukemia & Lymphoma. 2022 Aug 1
• 7 citations
  Early Antibiotic Discontinuation or De-escalation in High-Risk Patients With AML With Febrile Neutropenia and Prolonged Neutropenia.
  William Alegria, Bernard L Marini, Kevin Sellery Gregg, Dale Lee Bixby, Anthony Perissinotti, Jerod Nagel> ;Journal of the National Comprehensive Cancer Network. 2022 Feb 4
• 1 citations
  Real world outcomes in patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic stem cell transplantation-A single institution...
  Radhika Takiar, Charles E Foucar, Anthony J Perissinotti, Bernard L Marini, Lydia Benitez-Colon, Patrick W Burke, Dale L Bixby> ;Leukemia Research Reports. 2022 Jan 1
• Hematopoietic Stem and Progenitor Cells (HSPCs).
  Valeri H Terry, Gretchen E Zimmerman, Maria C Virgilio, Mark M Painter, Dale Bixby, Kathleen L Collins> ;Methods in Molecular Biology. 2022 Jan 1
• Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leuk...
  Alina Varabyeva, Christabel Pui-See Lo, Adamo Brancaccio, Anthony J. Perissinotti, Twisha S Patel, Katie Sandison, Lydia L. Benitez, Kristen Pettit, Patrick W. Burke, ...> ;Infection Control and Hospital Epidemiology. 2021 Oct 18
• 36 citations
  Phase 1/2 study of uproleselan added to chemotherapy in patients with relapsed or refractory acute myeloid leukemia.
  Daniel J. DeAngelo, Brian A. Jonas, Jane L. Liesveld, Dale L. Bixby, Anjali S. Advani, Paula Marlton, John L. Magnani, Helen M. Thackray, Eric J. Feldman, Michael O'Dw...> ;Blood. 2021 Sep 20
• 1 citations
  Retinal haemorrhage as a complication of blastic plasmacytoid dendritic cell neoplasm.
  Daniel A. Balikov, Dale L. Bixby, Rajesh C. Rao> ;The Lancet. Haematology. 2021 Sep 1
• 1 citations
  Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.
  Darren King, Charles E. Foucar, Vincent Ma, Lydia L. Benitez, Anthony J. Perissinotti, Bernard L. Marini, Dan R. Robinson, Rupali Roy Bhave, Dale L. Bixby> ;Cancer Genetics. 2021 Nov 1
• 2 citations
  Clinical Availability of ATRA for Patients With Suspected Acute Promyelocytic Leukemia: Why Guidelines May Not Be Followed.
  Marcus Geer, Charles E. Foucar, Sumana Devata, Lydia L. Benitez, Anthony J. Perissinotti, Bernard L. Marini, Dale L. Bixby> ;Journal of the National Comprehensive Cancer Network. 2021 Aug 17
• 7 citations
  Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase Inhibitors.
  Justin Shaya, Kristen Pettit, Malathi Kandarpa, Dale L. Bixby, Jessica Mercer, Moshe Talpaz> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jul 18
• 72 citations
  CPX-351 versus 7+3 cytarabine and daunorubicin chemotherapy in older adults with newly diagnosed high-risk or secondary acute myeloid leukaemia: 5-year results of a ra...
  Jeffrey E. Lancet, Geoffrey L. Uy, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Dale L. B...> ;The Lancet. Haematology. 2021 Jul 1
• 1 citations
  Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.
  Brian Bazzell, Bernard L. Marini, Lydia L. Benitez, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Anthony J. Perissinotti> ;Journal of Oncology Pharmacy Practice. 2021 Jun 1
• 8 citations
  Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia.
  Lydia L. Benitez, Anthony J. Perissinotti, Caitlin R. Rausch, Jeff Klaus, Stephen M Clark, Michael Filtz, Kelley L Ratermann, Carissa Treptow, Shawn Griffin, Marissa O...> ;Leukemia & Lymphoma. 2021 Apr 8
• 4 citations
  Utility of methicillin-resistant staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML).
  Millicynth Talagtag, Twisha S Patel, Gianni B. Scappaticci, Anthony J. Perissinotti, Allison J Schepers, Lindsay A Petty, Kristen Pettit, Patrick W. Burke, Dale L. Bix...> ;Transplant Infectious Disease. 2021 Apr 7
• 6 citations
  Comparative pharmacokinetic analysis of the blood-brain barrier penetration of dasatinib and ponatinib in mice.
  Karthik Ravi, Andrea Franson, Morgan J Homan, Holly Roberts, Manjunath P. Pai, Zachary Miklja, Miao He, Bo Wen, Lydia L. Benitez, Anthony J. Perissinotti, Dale L. Bixb...> ;Leukemia & Lymphoma. 2021 Mar 7
• Join now to see all

Journal Articles

• The FOSSIL Study: FLAG or Standard 7+3 Induction Therapy in Secondary Acute Myeloid Leukemia  
  Dale L Bixby, Ivan P Maillard, Moshe Talpaz, Leukemia Research
• A Phase 1 Trial of Vadastuximab Talirine Combined with Hypomethylating Agents in Patients with CD33 Positive AML  
  Eytan M Stein, Anand Jillella, Anthony S Stein, Amir T Fathi, Roland B Walter, Jeffrey E Lancet, Tibor J Kovacsovics, Anjali S Advani, Phoenix A Ho, Dale Bixby, Blood

Abstracts/Posters

• Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML
  Dale L. Bixby, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Aspacytarabine (BST-236) Is Safe and Efficacious As a Single-Agent, First-Line Therapy for Patients with Acute Myeloid Leukemia Unfit for Standard Chemotherapy. Integr...
  Dale L. Bixby, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• High E-Selectin Ligand Expression Contributes to Chemotherapy-Resistance in Poor Risk Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML) Patients and Can be Ov...
  Dale L. Bixby, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Efficacy and Safety of CPX-351 Versus 7+3 in a Subgroup of Older Patients with Newly Diagnosed Acute Myeloid Leukemia with Myelodysplasia-Related Changes (AML-MRC) Enr... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018